Approval · Notice of Compliance 25075 · 2021
TRELSTAR: Notice of Compliance 25075
Issued January 26, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25075
- Date
- January 26, 2021
- Company
- Knight Therapeutics Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of drug product manufacturing site and change in container closure integrity testing system
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRELSTAR | Not yet assigned | — |
Medicinal ingredients
- TRIPTORELIN PAMOATE 3.75 MG per DOSE
- TRIPTORELIN PAMOATE 11.25 MG per DOSE
- TRIPTORELIN PAMOATE 22.5 MG per DOSE